These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases]. Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446 [TBL] [Abstract][Full Text] [Related]
48. Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure. Jiang JR; Shih JY; Wang HC; Wu RM; Yu CJ; Yang PC J Formos Med Assoc; 2002 Dec; 101(12):871-4. PubMed ID: 12632823 [TBL] [Abstract][Full Text] [Related]
50. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer. Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255 [TBL] [Abstract][Full Text] [Related]
51. Sodium and calcium fluxes in a clonal nerve cell line. Stallcup WB J Physiol; 1979 Jan; 286():525-40. PubMed ID: 571466 [TBL] [Abstract][Full Text] [Related]
52. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743 [TBL] [Abstract][Full Text] [Related]
53. Palliative care for a patient with Lambert-Eaton myasthenic syndrome: role of 3,4-diaminopyridine. Chan KY; Chang RS; Lau VW; Chan ML; Lai T Ann Palliat Med; 2016 Oct; 5(4):311-314. PubMed ID: 27506750 [TBL] [Abstract][Full Text] [Related]
54. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions. Giovannini F; Sher E; Webster R; Boot J; Lang B Br J Pharmacol; 2002 Aug; 136(8):1135-45. PubMed ID: 12163346 [TBL] [Abstract][Full Text] [Related]
55. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome. Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874 [TBL] [Abstract][Full Text] [Related]
56. Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx. Takasugi J; Shimamura M; Koda T; Kishikawa T; Hanamoto A; Inohara H; Sato K; Morii E; Motomura M; Sakaguchi M; Nakatsuji Y; Mochizuki H Intern Med; 2018 Feb; 57(4):587-590. PubMed ID: 29093415 [TBL] [Abstract][Full Text] [Related]
57. Lambert-Eaton myasthenic syndrome. Mareska M; Gutmann L Semin Neurol; 2004 Jun; 24(2):149-53. PubMed ID: 15257511 [TBL] [Abstract][Full Text] [Related]
58. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen. Leveque C; Hoshino T; David P; Shoji-Kasai Y; Leys K; Omori A; Lang B; el Far O; Sato K; Martin-Moutot N Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3625-9. PubMed ID: 1314395 [TBL] [Abstract][Full Text] [Related]
59. [Small cell lung cancer with Lambert-Eaton myasthenic syndrome]. Tang XF Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Feb; 22(1):17-9, 61. PubMed ID: 2553355 [TBL] [Abstract][Full Text] [Related]
60. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma. Lipka AF; Verschuuren JJ; Titulaer MJ Ann N Y Acad Sci; 2012 Dec; 1275():70-7. PubMed ID: 23278580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]